Magnetic‐Powered Janus Cell Robots Loaded with Oncolytic Adenovirus for Active and Targeted Virotherapy of Bladder Cancer
- 27 May 2022
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 34 (26) , e2201042
Abstract
A unique robotic medical platform is designed by utilizing cell robots as the active “Trojan horse” of oncolytic adenovirus (OA), capable of tumor‐selective binding and killing. The OA‐loaded cell robots are fabricated by entirely modifying OA‐infected 293T cells with cyclic arginine–glycine–aspartic acid tripeptide (cRGD) to specifically bind with bladder cancer cells, followed by asymmetric immobilization of Fe3O4 nanoparticles (NPs) on the cell surface. OA can replicate in host cells and induce cytolysis to release the virus progeny to the surrounding tumor sites for sustainable infection and oncolysis. The asymmetric coating of magnetic NPs bestows the cell robots with effective movement in various media and wireless manipulation with directional migration in a microfluidic device and bladder mold under magnetic control, further enabling steerable movement and prolonged retention of cell robots in the mouse bladder. The biorecognition of cRGD and robust, controllable propulsion of cell robots work synergistically to greatly enhance their tissue penetration and anticancer efficacy in the 3D cancer spheroid and orthotopic mouse bladder tumor model. Overall, this study integrates cell‐based microrobots with virotherapy to generate an attractive robotic system with tumor specificity, expanding the operation scope of cell robots in biomedical community.Keywords
Funding Information
- National Key Research and Development Program of China (2017YFA0105900)
This publication has 64 references indexed in Scilit:
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016European Urology, 2017
- Bladder cancerThe Lancet, 2016
- Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specificallyCancer Letters, 2016
- The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder CancerBladder Cancer, 2016
- Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and AsiaCancer Treatment Reviews, 2016
- Wastewater Mediated Activation of Micromotors for Efficient Water CleaningNano Letters, 2015
- RBC micromotors carrying multiple cargos towards potential theranostic applicationsNanoscale, 2015
- EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic ObstructionEuropean Urology, 2015
- Neural Stem Cell-based Cell Carriers Enhance Therapeutic Efficacy of an Oncolytic Adenovirus in an Orthotopic Mouse Model of Human GlioblastomaMolecular Therapy, 2011
- Current Issues and Future Directions of Oncolytic AdenovirusesMolecular Therapy, 2010